Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Clinical trials advance medicine in the future. And help patients right now.

Jacob Thomas, MD
Conditions
September 9, 2019
Share
Tweet
Share

If you’ve ever used a medication to treat an illness, you have a clinical trial to thank for it. Every standard therapy used in medicine today once started as a clinical trial. And it is commonly understood that today’s clinical trials are shaping treatments of the future.

Less understood – but just as important – is the fact that clinical trials are helping patients right now.

From pancreatic cancer patients whose lives are extended far beyond current expectations, to patients with metastatic cancer who are taking back control of their lives, clinical trials are providing people in our community today with hope, help, and healing.

As a physician involved in various clinical trials, I am witnessing a remarkable evolution in medicine. My colleagues and I are using immunotherapy to “re-program” patients’ immune systems to fight cancer on their own. We are injecting chemotherapy directly into tumors to shrink cancer while minimizing risk to a patient’s healthy tissue. And we are using state-of-the-art genomic testing of tumors to develop more targeted and effective treatments.

Already, we are seeing impressive results, as clinical trials being conducted right here in Newport Beach are leading to safer, more effective, and longer-lasting cancer treatments.

There is a persistent misconception that early-phase clinical trials simply collect safety data, and don’t actually help patients, but that isn’t the case at all.

Clinical trials have advanced to the point that the early phase trials are now leading directly to FDA-approved treatments. We won’t engage in trials unless we believe they have the potential to immediately help our patients.

They also are designed to be safer than in the past. Any drug that makes it to a human clinical trial has already been through years of laboratory studies. Millions of dollars of research and countless hours of work have gone into making the treatment safe for humans.

That is part of the reason why today’s clinical trials lead to FDA approval much faster than trials of the past. By offering targeted and better-designed drugs, we can see a “home run” in a much earlier phase of a clinical trial.

We saw exactly this type of success late last year, when the FDA granted accelerated approval of larotrectinib, a treatment for cancers that have a specific genomic feature, or biomarker. In trials, the drug had a 75 percent overall response rate across different types of solid tumors. Some of the cancers treated by larotrectinib include soft tissue sarcoma, salivary gland cancer, infantile fibrosarcoma, thyroid cancer, and lung cancer.

Patients benefitted from these trials, and they are continuing to benefit. Deborah McCartney, whose stage 4 lung cancer had aggressively spread to her brain, lungs, and lymph nodes, told us she entered a clinical trial offering an experimental drug at Hoag because she wanted access to the most modern medicine possible.

Deborah echoed what we firmly believe: Standard treatments we offer today are not good enough – how can they be? We know that “tried and true” works, but the level of pain patients experience on the road to recovery, the recurrence rates and deaths tell us that we are not done striving.

When she entered the clinical trial, Deborah discovered a layered and rigorous process led by a thoughtful, experienced, and specialized team. Oversight and safety inform everything we do. Our team includes a clinical research director, program manager, clinical research nurses, and clinical research coordinators. We are adding new trials and growing our program continuously.

ADVERTISEMENT

All of us are working together – with patients and referring physicians – to advance medicine in the future and to help patients right now.

Historically, the only treatment options for cancer were surgery, radiation, and chemotherapy – your all-purpose cancer poison. Thanks to clinical trials, we are now entering an era that is more focused and sophisticated.

In the coming years, precision medicine, immunotherapy, and injectable therapies will take over where standard treatments have left off. We will have a tighter grip on cancer, a smarter approach to treatment and better, longer-lasting results.

And you’ll have clinical trials to thank for it.

Jacob Thomas is an oncologist, Hoag Memorial Hospital Presbyterian, Newport Beach, CA.

Image credit: Shutterstock.com

Prev

The medical profession needs more shadowing opportunities

September 8, 2019 Kevin 17
…
Next

Meet the orthopedic surgeon who became a rapper

September 9, 2019 Kevin 1
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
The medical profession needs more shadowing opportunities
Next Post >
Meet the orthopedic surgeon who became a rapper

ADVERTISEMENT

Related Posts

  • How social media can advance humanism in medicine

    Pooja Lakshmin, MD
  • When Western medicine fails patients and clinicians

    Kimberly Rogers, MD
  • Are patients using social media to attack physicians?

    David R. Stukus, MD
  • The excitement of clinical rotations: Not just learning medicine but doing medicine

    Orly Farber
  • How Big Medicine is hurting patients and putting small practices out of business

    John Machata, MD
  • A surprising example of how medicine is learned from our patients

    Aaron Grubner, MD

More in Conditions

  • Why regular exercise is the best prescription for lifelong health

    George F. Smith, MD
  • When the weight won’t budge: the hidden physiology of grief, stress, and set point

    Sarah White, APRN
  • Why peer support can save lives in high-pressure medical careers

    Maire Daugharty, MD
  • Addressing menstrual health inequities in adolescents

    Callia Georgoulis
  • Healing beyond the surface: Why proper chronic wound care matters

    Alvin May, MD
  • Why specialist pain clinics and addiction treatment services require strong primary care

    Olumuyiwa Bamgbade, MD
  • Most Popular

  • Past Week

    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • When a medical office sublease turns into a legal nightmare

      Ralph Messo, DO | Physician
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Eric Topol explores the science of super-agers and healthy aging [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why more doctors are leaving clinical practice and how it helps health care

      Arlen Meyers, MD, MBA | Physician
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why regular exercise is the best prescription for lifelong health

      George F. Smith, MD | Conditions
    • When the weight won’t budge: the hidden physiology of grief, stress, and set point

      Sarah White, APRN | Conditions
    • Why starting with why can transform your medical practice

      Neil Baum, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • When a medical office sublease turns into a legal nightmare

      Ralph Messo, DO | Physician
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Eric Topol explores the science of super-agers and healthy aging [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why more doctors are leaving clinical practice and how it helps health care

      Arlen Meyers, MD, MBA | Physician
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why regular exercise is the best prescription for lifelong health

      George F. Smith, MD | Conditions
    • When the weight won’t budge: the hidden physiology of grief, stress, and set point

      Sarah White, APRN | Conditions
    • Why starting with why can transform your medical practice

      Neil Baum, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...